Close Menu

NEW YORK – German cellular analytics firm Evorion Biotechnologies said on Tuesday that it has formed a strategic partnership with Jüke Systemtechnik and closed a financing round for an undisclosed amount to support commercialization of Evorion's cellular analysis platform.

Münster-based Evorion said that new and existing investors, including Jüke, participated in the financing round, with Jüke becoming an Evorion shareholder.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.